dexmedetomidine has been researched along with Anoxia, Brain in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, SH; Han, XR; Hu, B; Li, MQ; Lu, J; Shan, Q; Shen, M; Sun, CH; Wang, L; Wang, S; Wang, YJ; Wen, X; Wu, DM; Zhang, ZF; Zheng, YL | 1 |
| Franks, NP; Hossain, M; Ma, D; Maze, M; Rajakumaraswamy, N; Sanders, RD | 1 |
| Chen, Y; Hertz, L; Huang, R; Yu, AC | 1 |
3 other study(ies) available for dexmedetomidine and Anoxia, Brain
| Article | Year |
|---|---|
MicroRNA-140-5p elevates cerebral protection of dexmedetomidine against hypoxic-ischaemic brain damage via the Wnt/β-catenin signalling pathway.
Topics: Animals; Animals, Newborn; Apoptosis; beta Catenin; Cell Proliferation; Cerebral Cortex; Dexmedetomidine; Gene Expression Regulation; Humans; Hypoxia-Ischemia, Brain; Hypoxia, Brain; MicroRNAs; Neurons; Rats; Wnt Signaling Pathway; Wnt1 Protein | 2018 |
Neuroprotective interaction produced by xenon and dexmedetomidine on in vitro and in vivo neuronal injury models.
Topics: Adrenergic alpha-Agonists; Anesthetics, Inhalation; Animals; Brain Infarction; Carotid Artery, Common; Cell Hypoxia; Dexmedetomidine; Dose-Response Relationship, Drug; Drug Synergism; Glucose; Hypoxia, Brain; L-Lactate Dehydrogenase; Ligation; Mice; Mice, Inbred BALB C; Neuroglia; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Xenon | 2006 |
Dexmedetomidine-induced stimulation of glutamine oxidation in astrocytes: a possible mechanism for its neuroprotective activity.
Topics: Adrenergic alpha-Agonists; Animals; Astrocytes; Brain Ischemia; Carbon Dioxide; Carbon Radioisotopes; Cells, Cultured; Cerebral Cortex; Dexmedetomidine; Glutamic Acid; Glutamine; Hypoxia, Brain; Mice; Neuroprotective Agents; Neurotoxins; Oxidation-Reduction | 2000 |